Avrobio (AVRO) is said to be working with bankers to explore a potential sale after being approached by Novartis (NVS) about a takeover, a source told Street Insider. The price offered is "said to be more than quadruple the current market price," the source claimed, according to the blog report. Avrobio shares are up 20c, or 23%, to $1.07 following the report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on AVRO: